Xianwei Zeng Selected Research

Thrombectomy

5/2013

Safety and validity of mechanical thrombectomy and thrombolysis on severe cerebral venous sinus thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianwei Zeng Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 05/2016
5	Stroke (Strokes) 01/2022 - 02/2012
5	Ischemic Stroke 01/2021 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2018
3	Reperfusion Injury 01/2017 - 06/2011
2	Glioma (Gliomas) 10/2019 - 05/2016
2	Inflammation (Inflammations) 01/2018 - 01/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 07/2013
2	Brain Edema (Cerebral Edema) 07/2014 - 02/2012
2	Ischemia 07/2013 - 02/2012
1	COVID-19 02/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Coma (Comas) 01/2022
1	Cerebral Hemorrhage 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Dementia (Dementias) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Male Infertility (Male Sterility) 01/2018
1	Infarction (Infarctions) 01/2017
1	Diabetes Mellitus 09/2016
1	Atherosclerosis 09/2016
1	Astrocytoma (Pilocytic Astrocytoma) 05/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2013
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 05/2013
1	Edema (Dropsy) 02/2012
1	Cerebral Infarction 06/2011
1	Breast Neoplasms (Breast Cancer) 02/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2018
2	CytokinesIBA 01/2018 - 01/2017
2	Evans Blue (Blue, Evans)FDA Link 02/2012 - 06/2011
1	Therapeutic UsesIBA 10/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	AdiponectinIBA 01/2020
1	Proteasome InhibitorsIBA 10/2019
1	ONX 0912IBA 10/2019
1	Autophagy-Related ProteinsIBA 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	MyokinesIBA 05/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	LuciferasesIBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	Nicotine FDA Link 01/2018
1	Tacrine (Cognex)FDA Link 01/2018
1	AntibodiesIBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018
1	Bromodeoxyuridine (BrdU)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2016
1	Atorvastatin (Lipitor)FDA Link 09/2016
1	Protein Isoforms (Isoforms)IBA 05/2016
1	Temozolomide (Temodar)FDA LinkGeneric 05/2016
1	Messenger RNA (mRNA)IBA 05/2016
1	NeopterinIBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 07/2014
1	Oxygen (Dioxygen)IBA 07/2013
1	tyrosine receptor (receptor, tyrosine)IBA 07/2013
1	Cocaine (Cocaine HCl)IBA 07/2013
1	Glucose (Dextrose)FDA LinkGeneric 07/2013
1	Phosphotransferases (Kinase)IBA 07/2013
1	NeuropeptidesIBA 07/2013
1	Small Interfering RNA (siRNA)IBA 07/2013
1	Neuroprotective AgentsIBA 07/2013
1	Immunoglobulin G (IgG)IBA 07/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2013
1	Amphetamine (Amfetamine)FDA LinkGeneric 07/2013
1	Heparin (Liquaemin)FDA LinkGeneric 05/2013
1	Warfarin (Coumadin)FDA LinkGeneric 05/2013
1	Aquaporins (Water Channels)IBA 02/2012
1	Matrix Metalloproteinases (MMPs)IBA 02/2012
1	Ethanol (Ethyl Alcohol)IBA 02/2012
1	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2007

Therapy/Procedure

2	Therapeutics 01/2018 - 02/2011
1	Critical Care (Surgical Intensive Care) 02/2023
1	Ventriculostomy 01/2022
1	Perioperative Period 01/2022
1	Thrombectomy 05/2013
1	Ischemic Postconditioning 06/2011